Related Experiment Video
Updated: Sep 15, 2025

07:03
Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides
Published on: January 31, 2014
12.1K
Fluorescent collagen hybridizing peptide for quantifying collagen denaturation in cortical bone
William Woolley1, Naomi Chin1, S Michael Yu2
1Department of Mechanical and Aerospace Engineering, University of California San Diego, La Jolla 92093, CA, USA.
Bone Reports
|July 18, 2025
Summary
Bone fracture risk assessment needs better tools beyond bone mineral density (BMD). This study introduces Collagen Hybridizing Peptide (CHP) to quantify denatured collagen, a key factor in bone quality and fracture risk.
Area of Science:
- Biomaterials Science
- Orthopedics
- Biophysics
Background:
- Bone mineral density (BMD) is insufficient for assessing fracture risk as it overlooks bone quality.
- Collagen quality is crucial for bone toughness, but current methods cannot quantify denatured collagen in mineralized bone.
- Denatured collagen impairs bone's ability to dissipate energy, increasing fracture risk in conditions like osteoporosis and diabetes.
Purpose of the Study:
- To introduce and validate a novel tool, Collagen Hybridizing Peptide (CHP), for quantifying denatured collagen in cortical bone.
- To assess the correlation between CHP fluorescence and collagen denaturation.
- To investigate the localization of collagen denaturation in relation to mechanical strain in bone.
Main Methods:
- Development and application of fluorescent Collagen Hybridizing Peptide (CHP) for detecting denatured collagen in mineralized bone.
- Correlation analysis of CHP fluorescence with established trypsin-hydroxyproline assays for collagen denaturation.
- Confocal microscopy to visualize and quantify collagen denaturation in bone fracture surfaces.
Main Results:
- CHP fluorescence showed a strong correlation (r² = 0.99) with collagen denaturation levels.
- A 55% increase in collagen denaturation was observed when bone tissue strain exceeded the yield point.
- Fluorescent CHP successfully localized high-strain regions to areas of collagen denaturation on bone fracture surfaces.
Conclusions:
- Collagen Hybridizing Peptide (CHP) is a reliable, non-destructive tool for quantifying denatured collagen in cortical bone.
- Collagen damage, indicated by denaturation, occurs during post-yield failure and is linked to high-strain regions.
- CHP offers a new method to study the impact of collagen quality on bone fracture resistance, with applications in aging, osteoporosis, and diabetes research.

